Literature DB >> 8770661

Developmental changes in purine nucleotide metabolism in cultured rat astroglia.

E Zoref-Shani1, Y Bromberg, G Lilling, I Gozes, S Brosh, Y Sidi, O Sperling.   

Abstract

The present study was conducted in order to clarify the role of the glia in brain purine metabolism. This, in connection with the clarification of the etiology of the neurological manifestations associated with some of the inborn errors of purine metabolism in man. Purine nucleotide content, the capacity for de novo and salvage purine synthesis and the activity of several enzymes of purine nucleotide degradation, were assayed in primary cultures of rat astroglia in relation to culture age. The capacity of the intact cells to produce purine nucleotides de novo exhibited a marked decrease with the culture age, but the activity of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), catalyzing salvage nucleotide synthesis, increased. Aging was also associated with a marked increase in the activity of the degradation enzymes AMP deaminase, purine nucleoside phosphorylase (PNP) and guanine deaminase (guanase). The activity of adenosine deaminase and of AMP-5'-nucleotidase, increased markedly during the first 17 days in culture, but decreased thereafter. The results indicate that purine nucleotide metabolism in the cultured astroglia is changing with aging to allow the cells to maintain their nucleotide pool by reutilization of preformed hypoxanthine, rather than by de-novo production of new purines. Aging is also associated with increased capacity for operation of the adenine nucleotide cycle, contributing to the homeostasis of adenine nucleotides and to the energy charge of the cells. In principle, the age-related alterations in purine metabolism in the astroglia resemble those occurring in the maturating neurons, except for the capacity to produce purines de novo, which exhibited inverse trends in the two tissues. However, in comparison to the neurons, the cultured astroglia possess the capacity for a more intensive metabolism of purine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8770661     DOI: 10.1016/0736-5748(95)00054-2

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  4 in total

1.  Concentration of nucleosides and related compounds in cerebral and cerebellar cortical areas and white matter of the human brain.

Authors:  Katalin A Kékesi; Zsolt Kovács; Nóra Szilágyi; Mátyás Bobest; Tamás Szikra; Arpád Dobolyi; Gábor Juhász; Miklós Palkovits
Journal:  Cell Mol Neurobiol       Date:  2006-08-01       Impact factor: 5.046

2.  A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures.

Authors:  Dhaval P Bhatt; Xuesong Chen; Jonathan D Geiger; Thad A Rosenberger
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-02-13       Impact factor: 3.205

3.  Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice.

Authors:  S Brosh; P Boer; O Sperling; E Zoref-Shani
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

4.  High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer's Disease.

Authors:  Kun Xie; Qi Qin; Zhiping Long; Yihui Yang; Chenghai Peng; Chunyang Xi; Liangliang Li; Zhen Wu; Volontovich Daria; Yashuang Zhao; Fan Wang; Maoqing Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.